Cargando…

Purinergic Signalling in Allogeneic Haematopoietic Stem Cell Transplantation and Graft-versus-Host Disease

Allogeneic haematopoietic stem cell transplantation (allo-HSCT) is a curative therapy for blood cancers and other haematological disorders. However, allo-HSCT leads to graft-versus-host disease (GVHD), a severe and often lethal immunological response, in the majority of transplant recipients. Curren...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cuthbertson, Peter, Geraghty, Nicholas J., Adhikary, Sam R., Bird, Katrina M., Fuller, Stephen J., Watson, Debbie, Sluyter, Ronald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348324/ https://www.ncbi.nlm.nih.gov/pubmed/34361109 http://dx.doi.org/10.3390/ijms22158343

Ejemplares similares

Insights into mechanisms of graft-versus-host disease through humanised mouse models
por: Elhage, Amal, et al.
Publicado: (2022)

Use of Humanized Mouse Models to Investigate the Roles of Purinergic Signaling in Inflammation and Immunity
por: Sluyter, Ronald, et al.
Publicado: (2020)

A Species-Specific Anti-Human P2X7 Monoclonal Antibody Reduces Graft-versus-Host Disease in Humanised Mice
por: Elhage, Amal, et al.
Publicado: (2023)

Purinergic Signalling in Physiology and Pathophysiology
por: Sluyter, Ronald
Publicado: (2023)

Extracoporeal photopheresis treatment of acute graft-versus-host disease following allogeneic haematopoietic stem cell transplantation
por: Flinn, Aisling M., et al.
Publicado: (2016)

Expanding the use of allogeneic haematopoietic cell transplantation in dermatology
por: Bauer, J.W.
Publicado: (2021)

Application of latent class analysis in diagnosis of graft-versus-host disease by serum markers after allogeneic haematopoietic stem cell transplantation
por: Amini, Maedeh, et al.
Publicado: (2020)

Genomic prediction of relapse in recipients of allogeneic haematopoietic stem cell transplantation
por: Ritari, J., et al.
Publicado: (2018)

Editorial: purinergic signalling—perspectives from Australia and New Zealand
por: Sluyter, Ronald, et al.
Publicado: (2022)

Letermovir for Prophylaxis and Pre-emptive Therapy of Cytomegalovirus Infection in Paediatric Allogeneic Haematopoietic Cell Transplant Patients
por: Körholz, Katharina F., et al.
Publicado: (2022)

Soluble interleukin-27 receptor alpha is a valuable prognostic biomarker for acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation
por: Liu, Shuangzhu, et al.
Publicado: (2018)

Serotherapy as Graft-Versus-Host Disease Prophylaxis in Haematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukaemia
por: Keogh, Steven J., et al.
Publicado: (2022)

Relapsed Chronic Lymphocytic Leukaemia with Concomitant Extensive Chronic Graft versus Host Disease after Allogeneic Haematopoietic Stem Cell Transplantation Successfully Treated with Oral Venetoclax
por: Teoh, Ching Soon, et al.
Publicado: (2021)

Rehabilitation after Allogeneic Haematopoietic Stem Cell Transplantation: A Special Challenge
por: Bertz, Hartmut
Publicado: (2021)

Early-onset cardiac dysfunction following allogeneic haematopoietic stem cell transplantation
por: Moriyama, Shohei, et al.
Publicado: (2022)

Graft-versus-host disease in allogeneic transplantation: the good and the bad
por: Kröger, Nicolaus-Martin
Publicado: (2022)

High proportions of regulatory T cells in PBSC grafts predict improved survival after allogeneic haematopoietic SCT
por: Danby, R D, et al.
Publicado: (2016)

Purinergic Signalling in Group A Streptococcus Pathogenesis
por: McEwan, T. B-D, et al.
Publicado: (2022)

Pleuroparenchymal fibroelastosis after haematopoietic stem cell transplantation without graft‐versus‐host disease findings
por: Okimoto, Tamio, et al.
Publicado: (2018)

Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016
por: Ullmann, Andrew J., et al.
Publicado: (2016)

Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation
por: Marks, David I, et al.
Publicado: (2011)

Tumour-reactive B cells and antibody responses after allogeneic haematopoietic cell transplantation
por: de Jong, G., et al.
Publicado: (2020)

Metabolic Profiling Early Post-Allogeneic Haematopoietic Cell Transplantation in the Context of CMV Infection
por: Rasmussen, Kirstine K., et al.
Publicado: (2023)

P1312: CHARACTERISTICS OF MEMBRANOUS NEPHROPATHY AFTER ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Jin, Yue, et al.
Publicado: (2023)

Prognostic factors affecting the outcome after allogeneic haematopoietic stem cell transplantation for myelodysplastic syndrome
por: Belohlavkova, P, et al.
Publicado: (2021)

Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease
por: van Lier, Yannouck F., et al.
Publicado: (2023)

P1309: THE DIRECT HEALTHCARE BURDEN ASSOCIATED WITH CHRONIC GRAFT-VERSUS-HOST DISEASE FOLLOWING ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANT IN ENGLAND: A REAL-WORLD EVIDENCE ANALYSIS
por: Avenoso, Daniele, et al.
Publicado: (2023)

Immunogenicity of the inactivated influenza vaccine in children who have undergone allogeneic haematopoietic stem cell transplant
por: Ryan, Anne L., et al.
Publicado: (2019)

Long-term outcome following cyclosporine-related neurotoxicity in paediatric allogeneic haematopoietic stem cell transplantation
por: Straathof, K, et al.
Publicado: (2017)

Allogeneic Haematopoietic Stem Cell Transplantation as Therapy for Chronic Granulomatous Disease—Single Centre Experience
por: Goździk, Jolanta, et al.
Publicado: (2011)

Allogeneic haematopoietic stem cell transplantation from SARS-CoV-2 positive donors
por: Leclerc, Mathieu, et al.
Publicado: (2021)

Risk factors and outcomes of diffuse alveolar haemorrhage after allogeneic haematopoietic stem cell transplantation
por: Wu, Jin, et al.
Publicado: (2021)

Immune Reconstitution After Allogeneic Haematopoietic Cell Transplantation: From Observational Studies to Targeted Interventions
por: Yanir, Asaf, et al.
Publicado: (2022)

Impaired right ventricular function in long-term survivors of allogeneic haematopoietic stem-cell transplantation
por: Massey, Richard John, et al.
Publicado: (2021)

Editorial: Allogeneic haematopoietic stem cell transplantation for children with acute lymphoblastic leukaemia in the era of immunotherapy
por: Peters, Christina, et al.
Publicado: (2022)

The impact of donor type on resource utilisation and costs in allogeneic haematopoietic stem cell transplantation in the Netherlands
por: van Gorkom, Gwendolyn, et al.
Publicado: (2022)

Medication Adherence among Allogeneic Haematopoietic Stem Cell Transplant Recipients: A Systematic Review
por: Visintini, Chiara, et al.
Publicado: (2023)

P1673: UNEMPLOYMENT IN ADULT SURVIVORS OF ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANT IS ASSOCIATED WITH OLDER AGE, GRAFT VERSUS HOST DISEASE, HIGH PHYSICAL SYMPTOM BURDEN, AND IMPAIRED QUALITY OF LIFE
por: Douglas, Genevieve, et al.
Publicado: (2023)

P2X7 antagonism using Brilliant Blue G reduces body weight loss and prolongs survival in female SOD1(G93A) amyotrophic lateral sclerosis mice
por: Bartlett, Rachael, et al.
Publicado: (2017)

Computed tomography imaging of acute gastrointestinal graft-versus-host disease after haematopoietic stem cell transplantation in children
por: Arpaci, Taner
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ab38plqfirn2otll9rv9l29836